ad image

COVID-19 Therapeutics

1 / 1
AstraZeneca Canada
COVID-19 Prevention

AstraZeneca to Supply Canada with 100,000 Doses of Evusheld, a Long-Acting Antibody Combination for the Prevention of COVID-19

AstraZeneca Canada

PR-M02-22-21Feb 23, 2022
Model Medicines
COVID-19 Antiviral

Model Medicines' Oral Anti-COVID-19 Drug Candidate MDL-001 Found to Significantly Reduce Viral Load in Lungs; Accepted into NIH's Antiviral Program for Pandemics (APP)

Model Medicines

PR-M02-22-05Feb 08, 2022
Rapid Cleanroom Builds for COVID-19 Facilities: Lessons Learned
Cleanrooms

Rapid Cleanroom Builds for COVID-19 Facilities: Lessons Learned

Grant Merrill; Jose Jimenez

AES Clean Technology Inc.

PAO-06-21-CL-06Jun 18, 2021
Tevogen Bio
COVID-19 Therapeutics

Tevogen Bio Announces Partnership With BioCentriq to Enhance Tevogen’s Development Capacity of Its Proprietary Targeted T Cell Therapy For COVID-19

Tevogen Bio

PR-M03-21-002Mar 15, 2021
How an Agile Company Addressed the Pandemic: Moving from Psychiatric Medicines to a COVID-19 Therapeutic
COVID-19 Therapeutics

How an Agile Company Addressed the Pandemic: Moving from Psychiatric Medicines to a COVID-19 Therapeutic

Jonathan C. Javitt, M.D., M.P.H.

NeuroRx

PAP-Q4-20-CL-017Dec 09, 2020
Combating Cancer and Other Diseases with Supercharged NKT Cells
Natural Killer T cells

Combating Cancer and Other Diseases with Supercharged NKT Cells

Theresa Deisher, Ph.D.

AVM Biotechnology

PAP-Q4-20-CL-005Dec 09, 2020
1 / 1